Featured article: Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated TC cells

Thyroid Cancer. Credit: Darryl Leja, NHGRI.In this study, Notarangelo et al., evaluated the hypothesis that the exposure of BRAF-mutated thyroid carcinoma (TC) cells to vemurafenib results in EGFR feedback activation and that dual EGFR and BRAF blockade is superior to single agents. 

Read more

Image available on Flickr. License: CC BY 2.0.

Articles

View all articles

View all articles

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

Read more

Featured article: DMD transcripts in CRL-2061 RMS cells show high levels of intron retention

DMDThe DMD gene encoding dystrophin is mutated in Duchenne muscular dystrophy and has been shown to act as a tumor suppressor. Rhabdomyosarcoma (RMS) is a mesodermal sarcoma that shares characteristics of skeletal muscle precursors. In this article, Niba et al., analyze DMD products in CRL-2061 cells established from alveolar rhabdomyosarcoma.

Read more

Advertisement